Clinical Trials Directory

Trials / Completed

CompletedNCT03191643

PET-guided External Beam Radiotherapy in Differentiated Thyroid Cancer

18F-FDG PET-guided External Beam Radiotherapy in Iodine-refractory Differentiated Thyroid Cancer

Status
Completed
Phase
Study type
Observational
Enrollment
16 (actual)
Sponsor
IRCCS Azienda Ospedaliero-Universitaria di Bologna · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Description of the role of a post-operative external beam radiotherapy in patients with differentiated thyroid cancer.

Detailed description

The role of post-operative external beam radiotherapy (EBRT) in differentiated thyroid cancer is still discussed considering the low clinical aggressiveness and the availability of ablative 131Iodine therapy. However, there is a subgroup of tumors which lose the ability to capture Iodine over time. This study wants to describe the role of a post-operative external beam radiotherapy in patients with differentiated thyroid cancer.

Conditions

Timeline

Start date
2011-10-01
Primary completion
2016-01-31
Completion
2016-01-31
First posted
2017-06-19
Last updated
2017-06-19

Source: ClinicalTrials.gov record NCT03191643. Inclusion in this directory is not an endorsement.

PET-guided External Beam Radiotherapy in Differentiated Thyroid Cancer (NCT03191643) · Clinical Trials Directory